Abstract
There is currently no coordinated global effort to examine the possibilities offered by traditional, complementary and integrative medicine (TCIM) for the fight against antimicrobial resistance (AMR) despite there being numerous substances that are currently in use and understood to be highly effective. TCIM could significantly alter medical outcomes at low cost. Some traditional medicine disciplines have begun research into these areas, but nowhere is there a coordinated effort to summarise the research by pathogen, identify gaps, nor undertake a prioritised program of work to further the research. The lack of commercial benefit to be derived from new antimicrobials with likely inbuilt obsolescence and usage restrictions drives this pharmaceutical R and D lag. Similarly, market incentives have been lacking or ineffective.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Australian Journal of Herbal and Naturopathic Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
